PURDUE PHARMA L.P. v. IANCU , No. 18-1285 (Fed. Cir. 2019)

Annotate this Case

Download PDF

NOTE: This disposition is nonprecedential. United States Court of Appeals for the Federal Circuit ______________________ PURDUE PHARMA L.P., P.F. LABORATORIES, INC., PURDUE PHARMACEUTICALS L.P., Appellants v. ANDREI IANCU, UNDER SECRETARY OF COMMERCE FOR INTELLECTUAL PROPERTY AND DIRECTOR OF THE UNITED STATES PATENT AND TRADEMARK OFFICE, Intervenor ______________________ 2018-1285, 2018-1286 ______________________ Appeals from the United States Patent and Trademark Office, Patent Trial and Appeal Board in Nos. IPR201601027, IPR2016-01028. ______________________ JUDGMENT ______________________ JENNIFER LORAINE SWIZE, Jones Day, Washington, DC, argued for appellants. Also represented by ROBERT STANDER, GREGORY A. CASTANIAS; GASPER LAROSA, JOHN JOSEPH NORMILE, JR., New York, NY. SARAH E. CRAVEN, Office of the Solicitor, United States Patent and Trademark Office, Alexandria, VA, argued for intervenor. Also represented by THOMAS W. KRAUSE, MARY L. KELLY, JOSEPH MATAL. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (DYK, MAYER, and BRYSON, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36. ENTERED BY ORDER OF THE COURT April 4, 2019 Date /s/ Peter R. Marksteiner Peter R. Marksteiner Clerk of Court

Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.